HCV genome variability in acute and chronic viral hepatitis C

HCV genome variability in acute and chronic viral hepatitis C

Aim. To evaluate HCV genome variability in acute and chronic phases of viral hepatitis C. Material and methods. The study of heterogeneity of HCV in acute hepatitis C has detected genetic heterogeneity and variability of individual HCV population circulating in the blood. Significant genetic heterog...

Full description

Bibliographic Details
Main Authors:	N D Yushchuk, E A Klimova, O O Znoyko, M M Gadzhikulieva, E N Il'ina, T L Yashina, N A Malyshev, E V Tsyganova, N D Yuschuk, O O Znoiko, E N Ilyina
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2009-04-01
Series:	Терапевтический архив
Subjects:	genetic hcv heterogeneity acute and chronic hepatitis c sscp-analysis isdr resistance to interferon
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/30313

Similar Items

Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs
by: Stefania Paolucci, et al.
Published: (2020-02-01)

The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study
by: Juferdy Kurniawan, et al.
Published: (2019-08-01)

Multi-Risk Assessment and Management—A Comparative Study of the Current State of Affairs in Chile and Ecuador
by: Stefan Greiving, et al.
Published: (2021-01-01)

Analysis of ineffective antiviral therapy with pegylated interferon and ribavirin in a patient with chronic hepatitis C infected with HCV genotype 2
by: O O Znoyko, et al.
Published: (2016-05-01)

Detection rate of specific antibodies to the HCV CORE+1 protein in “naive” cronically HCV-infected patients in depends on the stage of liver fibrosis and the HCV subtype
by: E. V. Lichnaya, et al.
Published: (2021-01-01)

Chronic HCV infection: An internist’s opinion (Part 2)
by: M L Zubkin, et al.
Published: (2016-11-01)

Distribution of HCV genotypes among different exposure categories in Brazil
by: Oliveira M.L.A., et al.
Published: (1999-01-01)

Anti-HCV related to HCV PCR and risk factors analysis in a blood donor population of Central Brazil Anticorpo anti-HCV relacionado a detecção do HCV por PCR e análise de fatores de risco em uma população de doadores de sangue do Brasil Central
by: R. M. B. Martins, et al.
Published: (1994-12-01)

Role of IL6 –174C/G gene polymorphism in development of chronic HCV infection
by: N. A. Semyonova, et al.
Published: (2010-10-01)

Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project
by: Alessio, L., et al.
Published: (2022)

Features of combined (hbv/hcv-infection) viral lesion of the liver
by: I V Maev, et al.
Published: (2008-02-01)

Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community
by: Wei-Ming Chen, et al.
Published: (2021-05-01)

Induction of HCV-specific cell response in vitro by dendritic cells generated with interferon-α
by: E. R. Chernykh, et al.
Published: (2019-05-01)

Variety of genotypes of a HCV virus and outcomes of chronic hepatitis C: results 5 summer supervision in the territory of the Kirov region
by: S. V. Baramzina, et al.
Published: (2014-09-01)

FEATURES OF CIRCULATION OF HEPATITIS C VIRUS IN KHABAROVSK REGION
by: N. V. Soboleva, et al.
Published: (2017-06-01)

Influence of HCV-Infection on the Development of Diabetes Mellitus Type 1
by: O.V. Gulinskaya, et al.
Published: (2014-02-01)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
by: Ashfaq Usman Alli A, et al.
Published: (2011-06-01)

Antiretrovirus drugs impair kidneys in HIV-infection
by: Nikolay Dmitrievich Yushchuk, et al.
Published: (2011-11-01)

Renal damage in HIV infection
by: N D Yushchuk, et al.
Published: (2008-12-01)

Recent epidemiological trends in HCV-infection in Ukraine
by: T. N. Shevchenko, et al.
Published: (2017-04-01)

Diagnostic performance of an immunoassay for simultaneous detection of HCV core antigen and antibodies among haemodialysis patients
by: Wafaa M El-Emshaty, et al.
Published: (2011-03-01)

Comparative studies in detection of anti-HCV antibodies using Abbott IMx HCV, Serodia-HCV and DETECT-HCVTM
by: Nisarat Apichartpiyakul, et al.
Published: (2010-01-01)

The prevalence of the hepatitis C virus among the conditionally healthy population of the Russian Federation
by: N. V. Soboleva, et al.
Published: (2017-06-01)

Primary HCV Drug Resistance Mutations in Patients with Newly Diagnosed HIV Infection
by: Yu. V. Ostankova, et al.
Published: (2020-10-01)

The first experience of non-interferon therapy of HCV infection in patients with Wilson-Konovalov’s disease
by: T P Rozina, et al.
Published: (2018-11-01)

Immunogenetic predictors of a rapid virologic response to antiviral therapy in patients with chronic hepatitis C
by: N D Iushchuk, et al.
Published: (2012-11-01)

The Distribution of Hepatitis C Virus (HCV) Genotypes in 59 HCV Infected Patients: A Multicenter Study
by: Emine SÖNMEZ, et al.
Published: (1996-06-01)

The Case of anti-HCV Negative Chronic Hepatitis C
by: A. L. Rossina, et al.
Published: (2015-12-01)

Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil
by: M.L.A. Oliveira, et al.
Published: (1999-09-01)

Spontaneous HCV clearance: an association with gender, age, viral genotypes, infection transmission routes, and markers of HBV and HIV
by: Sergey Valer'evich Fedorchenko, et al.
Published: (2010-03-01)

Sofosbuvir in therapy of chronic HCV-infection
by: C. S. Pavlov, et al.
Published: (2016-12-01)

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV–HCV co-infected patients: final results of the Spanish BOC HIV–HCV Study
by: M. Laguno, et al.
Published: (2016-12-01)

Single Strand Conformation Polymorphism analysis of PCR-amplified rDNA to differentiate medically important Aspergillus Species
by: K Diba, et al.
Published: (2008-09-01)

Single Strand Conformation Polymorphism analysis of PCR-amplified rDNA to differentiate medically important Aspergillus Species
by: K Diba, et al.
Published: (2008-09-01)

Epidemiology of hepatitis C in the Moscow Region: data from the Moscow Regional Registry and screening for HCV antibodies
by: P. O. Bogomolov, et al.
Published: (2016-09-01)

INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY
by: E. R. Chernykh, et al.
Published: (2017-08-01)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
by: Rujipat Wasitthankasem, et al.
Published: (2017-11-01)

Peripheral B cells as reservoirs for persistent HCV infection
by: Masahiko eIto, et al.
Published: (2011-08-01)

Apical hypertrophic cardiomyopathy associated with HCV infection
by: Viktor Viktorovich Fomin, et al.
Published: (2011-01-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)